Pyrazinamide.svg

Multicountry surveillance of resistance to Z and FLQs

A new publication on multicountry surveillance of resistance to Z and FLQs was published in LancetInfectDis2016 on July 7, 2016: http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(16)30190-6.pdf Background Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available. Methods In a molecular epidemiology Read more››

2016_dr_tb_guidelines_large

WHO guidelines on multidrug-resistant tuberculosis (MDR-TB)

Recently, the WHO published long-awaited updated WHO guidelines on multidrug-resistant tuberculosis (MDR-TB): http://www.who.int/tb/MDRTBguidelines2016.pdf?ua=1.  The USAID Strengthening TB Control in Ukraine project has prepared a short summary of the most important recommendations from the guidelines for the Ukrainian health specialists (download in Ukrainian). Like all WHO recommendations, this document has a considerable evidence base. Even compared Read more››

Seminar in Odesa: “Improving TB Treatment, including MDR TB and TB/HIV, through Implementation of International Standards on Side Effects Management”

On June 9, 2016, USAID “Strengthening Tuberculosis (TB) Control in Ukraine” Project will hold a seminar on "Improving TB Treatment, including MDR TB and TB/HIV, through Implementation of International Standards on Side Effects Management" for TB specialists in the Odesa oblast. The purpose of the workshop is to promote more effective TB treatment through reducing the period Read more››


1 2 3 4 13 Page 1 of 13